The Association Between Risk Factors for Metabolic Syndrome and Meibomian Gland Disease in a Dry Eye Cohort

References

• Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276–283. doi:10.1016/j.jtos.2017.05.008
   PubMed Web of Science ®Google Scholar
• Tang YL, Cheng YL, Ren YP, et al. Metabolic syndrome risk factors and dry eye syndrome: a meta-analysis. Int J Ophthalmol. 2016;9(7):1038–1045.
   Web of Science ®Google Scholar
• Lemp MA, Foulks GN. The epidemiology of dry eye disease: report of the epidemiology subcommittee of the international dry eye workshop (2007). Ocul Surf. 2007;5(2):93–107. doi:10.1016/S1542-0124(12)70082-4
   Web of Science ®Google Scholar
• Paulsen AJ, Cruickshanks KJ, Fischer ME, et al. Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life. Am J Ophthalmol. 2014;157(4):799–806. doi:10.1016/j.ajo.2013.12.023
   PubMed Web of Science ®Google Scholar
• Schaumberg DA, Sullivan DA, Buring JE, et al. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136(2):318–326. doi:10.1016/S0002-9394(03)00218-6
   PubMed Web of Science ®Google Scholar
• Schaumberg DA. Prevalence of dry eye disease among US men: estimates from the physicians’ health studies. Arch Ophthalmol. 2009;127(6):763–768. doi:10.1001/archophthalmol.2009.103
   PubMedGoogle Scholar
• Geerling G, Baudouin C, Aragona P, et al. Emerging strategies for the diagnosis and treatment of meibomian gland dysfunction: proceedings of the OCEAN group meeting. Ocul Surf. 2017;15(2):179–192. doi:10.1016/j.jtos.2017.01.006
   PubMed Web of Science ®Google Scholar
• Chhadva P, Goldhardt R, Galor A. Meibomian gland disease: the role of gland dysfunction in dry eye disease. Ophthalmology. 2017;124(11):S20–S26. doi:10.1016/j.ophtha.2017.05.031
   PubMed Web of Science ®Google Scholar
• Shine WE, McCulley JP. Role of wax ester fatty alcohols in chronic blepharitis. Invest Ophthalmol Vis Sci. 1993;34(13):3515–3521.
   Web of Science ®Google Scholar
• Green-Church KB, Butovich I, Willcox M, et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on tear film lipids and lipid-protein interactions in health and disease. Invest Ophthalmol Vis Sci. 2011;52(4):1979–1993. doi:10.1167/iovs.10-6997d
   PubMed Web of Science ®Google Scholar
• Butovich IA. Tear film lipids. Exp Eye Res. 2013;117:4–27. doi:10.1016/j.exer.2013.05.010
   PubMed Web of Science ®Google Scholar
• Shine WE, McCulley JP. Polar lipids in human meibomian gland secretions. Curr Eye Res. 2003;26(2):89–94. doi:10.1076/ceyr.26.2.89.14515
   PubMed Web of Science ®Google Scholar
• Rabensteiner DF, Aminfar H, Boldin I, et al. The prevalence of meibomian gland dysfunction, tear film and ocular surface parameters in an Austrian dry eye clinic population. Acta Ophthalmol. 2018;96(6):e707–e711. doi:10.1111/aos.13732
   PubMed Web of Science ®Google Scholar
• Hassanzadeh S, Varmaghani M, Zarei-Ghanavati S, et al. Global prevalence of meibomian gland dysfunction: a systematic review and meta-analysis. Ocul Immunol Inflamm. 2021;29(1):66–75. doi:10.1080/09273948.2020.1755441
   PubMed Web of Science ®Google Scholar
• Di Pascuale MA. Clinical characteristics of conjunctivochalasis with or without aqueous tear deficiency. Br J Ophthalmol. 2004;88(3):388–392. doi:10.1136/bjo.2003.025460
   Web of Science ®Google Scholar
• Jester JV, Parfitt GJ, Brown DJ. Meibomian gland dysfunction: hyperkeratinization or atrophy? BMC Ophthalmol. 2015;15 Suppl 1(Suppl 1):156. doi:10.1186/s12886-015-0132-x
   Web of Science ®Google Scholar
• Parfitt GJ, Xie Y, Geyfman M, et al. Absence of ductal hyper-keratinization in mouse age-related meibomian gland dysfunction (ARMGD). Aging (Albany NY). 2013;5(11):825–834. doi:10.18632/aging.100615
   PubMedGoogle Scholar
• Eom Y, Lee J-S, Kang S-Y, et al. Correlation between quantitative measurements of tear film lipid layer thickness and meibomian gland loss in patients with obstructive meibomian gland dysfunction and normal controls. Am J Ophthalmol. 2013;155(6):1104–1110.e2. doi:10.1016/j.ajo.2013.01.008
   PubMed Web of Science ®Google Scholar
• Craig JP, Tomlinson A. Importance of the lipid layer in human tear film stability and evaporation. Optom Vis Sci. 1997;74(1):8–13. doi:10.1097/00006324-199701000-00014
   PubMed Web of Science ®Google Scholar
• Alberti KG. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–1645.
   PubMed Web of Science ®Google Scholar
• O’Neill LA, Pearce EJ. Immunometabolism governs dendritic cell and macrophage function. J Exp Med. 2016;213(1):15–23. doi:10.1084/jem.20151570
   PubMed Web of Science ®Google Scholar
• Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20(2):12. doi:10.1007/s11906-018-0812-z
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhao L, Deng S, et al. Dry eye syndrome in patients with diabetes mellitus: prevalence, etiology, and clinical characteristics. J Ophthalmol. 2016;2016:8201053. doi:10.1155/2016/8201053
   PubMed Web of Science ®Google Scholar
• Cai D, Zhu M, Petroll WM, et al. The impact of type 1 diabetes mellitus on corneal epithelial nerve morphology and the corneal epithelium. Am J Pathol. 2014;184(10):2662–2670. doi:10.1016/j.ajpath.2014.06.016
   PubMed Web of Science ®Google Scholar
• Yoo TK, Oh E. Diabetes mellitus is associated with dry eye syndrome: a meta-analysis. Int Ophthalmol. 2019;39(11):2611–2620. doi:10.1007/s10792-019-01110-y
   PubMed Web of Science ®Google Scholar
• Huang X, Zhang P, Zou X, et al. Two-year incidence and associated factors of dry eye among residents in shanghai communities with type 2 diabetes mellitus. Eye Contact Lens. 2020;46(Suppl 1):S42–s49. doi:10.1097/ICL.0000000000000626
   Web of Science ®Google Scholar
• Alves Mde C. Tear film and ocular surface changes in diabetes mellitus. Arq Bras Oftalmol. 2008;71(6 Suppl):96–103. doi:10.1590/S0004-27492008000700018
   PubMed Web of Science ®Google Scholar
• Markoulli M, Flanagan J, Tummanapalli SS, et al. The impact of diabetes on corneal nerve morphology and ocular surface integrity. Ocul Surf. 2018;16(1):45–57. doi:10.1016/j.jtos.2017.10.006
   PubMed Web of Science ®Google Scholar
• Cousen P, Cackett P, Bennett H, et al. Tear production and corneal sensitivity in diabetes. J Diabetes Complications. 2007;21(6):371–373. doi:10.1016/j.jdiacomp.2006.05.008
   PubMed Web of Science ®Google Scholar
• Ramos-Remus C, Suarez-Almazor M, Russell AS. Low tear production in patients with diabetes mellitus is not due to Sjögren’s syndrome. Clin Exp Rheumatol. 1994;12(4):375–380.
   PubMed Web of Science ®Google Scholar
• Hosaka E, Kawamorita T, Ogasawara Y, et al. Interferometry in the evaluation of precorneal tear film thickness in dry eye. Am J Ophthalmol. 2011;151(1):18–23.e1. doi:10.1016/j.ajo.2010.07.019
   PubMed Web of Science ®Google Scholar
• Yu T. Changes of meibomian glands in patients with type 2 diabetes mellitus. Int J Ophthalmol. 2016;9(12):1740–1744.
   PubMed Web of Science ®Google Scholar
• Sandra Johanna GP, Antonio LA, Andrés GS. Correlation between type 2 diabetes, dry eye and Meibomian glands dysfunction. J Optom. 2019;12(4):256–262. doi:10.1016/j.optom.2019.02.003
   PubMedGoogle Scholar
• Lin X, Xu B, Zheng Y, et al. Meibomian gland dysfunction in type 2 diabetic patients. J Ophthalmol. 2017;2017:3047867. doi:10.1155/2017/3047867
   PubMed Web of Science ®Google Scholar
• Erdur SK, Aydin R, Ozsutcu M, et al. The relationship between metabolic syndrome, its components, and dry eye: a cross-sectional study. Curr Eye Res. 2017;42(8):1115–1117. doi:10.1080/02713683.2017.1280511
   PubMed Web of Science ®Google Scholar
• Braich PS, Howard MK, Singh JS. Dyslipidemia and its association with meibomian gland dysfunction. Int Ophthalmol. 2016;36(4):469–476. doi:10.1007/s10792-015-0149-4
   PubMed Web of Science ®Google Scholar
• Chen A, Chen H-T, Chen H-C, et al. Asymptomatic meibomian gland dysfunction and cardiovascular disease risk factors in a middle-aged population in Taiwan - a cross-sectional analysis. Sci Rep. 2017;7(1):4935. doi:10.1038/s41598-017-05368-z
   Web of Science ®Google Scholar
• Pinna A, Blasetti F, Zinellu A, et al. Meibomian gland dysfunction and hypercholesterolemia. Ophthalmology. 2013;120(12):2385–2389. doi:10.1016/j.ophtha.2013.05.002
   PubMed Web of Science ®Google Scholar
• Guliani BP, Bhalla A, Naik MP. Association of the severity of meibomian gland dysfunction with dyslipidemia in Indian population. Indian J Ophthalmol. 2018;66(10):1411–1416. doi:10.4103/ijo.IJO_1256_17
   Web of Science ®Google Scholar
• Bukhari AA. Associations between the grade of meibomian gland dysfunction and dyslipidemia. Ophthalmic Plast Reconstr Surg. 2013;29(2):101–103. doi:10.1097/IOP.0b013e31827a007d
   Web of Science ®Google Scholar
• Dao AH, Spindle JD, Harp BA, et al. Association of dyslipidemia in moderate to severe meibomian gland dysfunction. Am J Ophthalmol. 2010;150(3):371–375.e1. doi:10.1016/j.ajo.2010.04.016
   Web of Science ®Google Scholar
• Jong MC, Gijbels MJ, Dahlmans VE, et al. Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein C1. J Clin Invest. 1998;101(1):145–152. doi:10.1172/JCI791
   Web of Science ®Google Scholar
• Guldur T, Bayraktar Ν, Kaynar Ö, et al. Excretion rate and composition of skin surface lipids on the foreheads of adult males with type IV hyperlipoproteinemia. J Basic Clin Physiol Pharmacol. 2007;18(1):21–35. doi:10.1515/JBCPP.2007.18.1.21
   Google Scholar
• Fernandez-Armenteros JM. Psoriasis, metabolic syndrome and cardiovascular risk factors. A population-based study. J Eur Acad Dermatol Venereol. 2018;33(1):128–135. doi:10.1111/jdv.15159
   Web of Science ®Google Scholar
• Choudhary S, Pradhan D, Pandey A, et al. The association of metabolic syndrome and psoriasis: a systematic review and meta-analysis of observational study. Endocr Metab Immune Disord Drug Targets. 2020;20(5):703–717. doi:10.2174/1871530319666191008170409
   PubMed Web of Science ®Google Scholar
• Butovich IA. Meibomian glands, meibum, and meibogenesis. Exp Eye Res. 2017;163:2–16. doi:10.1016/j.exer.2017.06.020
   PubMed Web of Science ®Google Scholar
• Rittié L, Tejasvi T, Harms PW, et al. Sebaceous gland atrophy in psoriasis: An explanation for psoriatic alopecia? J Invest Dermatol. 2016;136(9):1792–1800. doi:10.1016/j.jid.2016.05.113
   Web of Science ®Google Scholar
• Bagchi S. CD1b-autoreactive T cells contribute to hyperlipidemia-induced skin inflammation in mice. J Clin Invest. 2017;127(6):2339–2352. doi:10.1172/JCI92217
   PubMed Web of Science ®Google Scholar
• Shahine A. The intricacies of self-lipid antigen presentation by CD1b. Mol Immunol. 2018;104:27–36. doi:10.1016/j.molimm.2018.09.022
   PubMed Web of Science ®Google Scholar
• Bagchi S, Genardi S, Wang C-R. Linking CD1-restricted T cells with autoimmunity and dyslipidemia: lipid levels matter. Front Immunol. 2018;9:1616.
   Web of Science ®Google Scholar